One year changes in disability in multiple sclerosis: neurological examination compared with patient self report

被引：35

作者：

Hoogervorst, ELJ

Eikelenboom, MJ

Uitdehaag, BMJ

Polman, CH

机构：

[1] VU Med Ctr, Dept Neurol, Amsterdam, Netherlands

[2] VU Med Ctr, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands

来源：

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2003年 / 74卷 / 04期

关键词：

D O I：

10.1136/jnnp.74.4.439

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：439 / 442

页数：4

共 21 条

[1] Interferon-β1b in the treatment of secondary progressive MS -: Impact on quality of life [J].

Freeman, JA ;

Thompson, AJ ;

Fitzpatrick, R ;

Hutchinson, M ;

Miltenburger, C ;

Beckmann, K ;

Dahlke, F ;

Kappos, L ;

Polman, C ;

Pozzilli, C .

NEUROLOGY, 2001, 57 (10) :1870-1875

[2] EDSS RELIABILITY [J].

GOODKIN, DE .

NEUROLOGY, 1991, 41 (02) :332-332

[3] Kurtzke scales revisited: the application of psychometric methods to clinical intuition [J].

Hobart, J ;

Freeman, J ;

Thompson, A .

BRAIN, 2000, 123 :1027-1040

[4]

Hohol MJ, 1999, MULT SCLER, V5, P349, DOI 10.1177/135245859900500508

[5]

Hoogervorst ELJ, 2001, MULT SCLER, V7, P335

[6] Comparisons of patient self-report, neurologic examination, and functional impairment in MS [J].

Hoogervorst, ELJ ;

van Winsen, LML ;

Eikelenboom, MJ ;

Kalkers, NF ;

Uitdehaag, BMJ ;

Polman, CH .

NEUROLOGY, 2001, 56 (07) :934-937

[7] Intramuscular interferon beta-1 alpha for disease progression in relapsing multiple sclerosis [J].

Jacobs, LD ;

Cookfair, DL ;

Rudick, RA ;

Herndon, RM ;

Richert, JR ;

Salazar, AM ;

Fischer, JS ;

Goodkin, DE ;

Granger, CV ;

Simon, JH ;

Alam, JJ ;

Bartoszak, DM ;

Bourdette, DN ;

Braiman, J ;

Brownscheidle, CM ;

Coats, ME ;

Cohan, SL ;

Dougherty, DS ;

Kinkel, RP ;

Mass, MK ;

Munschauer, FE ;

Priore, RL ;

Pullicino, PM ;

Scherokman, BJ ;

WeinstockGuttman, B ;

Whitman, RH ;

Baird, WC ;

Fillmore, M ;

Bona, LM ;

ColonRuiz, ME ;

Nadine, BS ;

Donovan, A ;

Bennett, S ;

Kieffer, YM ;

Umhauer, MA ;

Miller, CE ;

Kilic, AK ;

Sargent, EL ;

Schachter, M ;

Shucard, DW ;

Weider, V ;

Catalano, BA ;

Cervi, JM ;

Czekay, C ;

Farrell, JL ;

Filippini, JS ;

Matyas, RC ;

Michienzi, KE ;

Ito, M ;

OMalley, JA .

ANNALS OF NEUROLOGY, 1996, 39 (03) :285-294

[8] Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis [J].

Kappos, L ;

Polman, C ;

Pozzilli, C ;

Thompson, A ;

Dahlke, F ;

Knight, R ;

Hern, J ;

Coleman, R ;

Gerrie, L ;

Cooper, G ;

Moore, J ;

Boringa, J ;

van Oosten, B ;

Ronner, H ;

Schrijver, H ;

Truyen, L ;

Montalbán, J ;

Río, J ;

Tintoré, M ;

Jacas, C ;

Marzo, E ;

Lechner-Scott, J ;

Huber, S ;

Lienert, C ;

Brunnschweiler, H ;

Hawkins, S ;

Droogan, A ;

McDonnell, G ;

Duddy, M ;

McKinstry, S ;

Altenkirch, H ;

Baum, K ;

Einhäupl, K ;

Marx, P ;

Poewe, W ;

Walter, G ;

Akman, H ;

Brockmeier, B ;

Scherer, P ;

Zschenderlein, R ;

Schmierer, K ;

Gelderblom, H ;

Hartmann, A ;

Stapf, C ;

Lüschow, A ;

Mackert, B ;

Schumacher, H ;

Masuhr, F ;

Hempel, T ;

Zimmermann, R .

LANCET, 1998, 352 (9139) :1491-1497

[9]

King J, 2001, NEUROLOGY, V56, P1496

[10]

KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444

← 1 2 3 →